Cargando…
Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276236/ https://www.ncbi.nlm.nih.gov/pubmed/34267730 http://dx.doi.org/10.3389/fendo.2021.719647 |
| _version_ | 1783721866903420928 |
|---|---|
| author | Esteves, Sandro C. Andersen, Claus Yding Fischer, Robert Humaidan, Peter Alviggi, Carlo |
| author_facet | Esteves, Sandro C. Andersen, Claus Yding Fischer, Robert Humaidan, Peter Alviggi, Carlo |
| author_sort | Esteves, Sandro C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8276236 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82762362021-07-14 Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW Esteves, Sandro C. Andersen, Claus Yding Fischer, Robert Humaidan, Peter Alviggi, Carlo Front Endocrinol (Lausanne) Endocrinology Frontiers Media S.A. 2021-06-29 /pmc/articles/PMC8276236/ /pubmed/34267730 http://dx.doi.org/10.3389/fendo.2021.719647 Text en Copyright © 2021 Esteves, Andersen, Fischer, Humaidan and Alviggi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Endocrinology Esteves, Sandro C. Andersen, Claus Yding Fischer, Robert Humaidan, Peter Alviggi, Carlo Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW |
| title | Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW |
| title_full | Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW |
| title_fullStr | Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW |
| title_full_unstemmed | Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW |
| title_short | Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW |
| title_sort | editorial: poseidon’s stratification of ‘low prognosis’ patients in art: the why, the what, and the how |
| topic | Endocrinology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276236/ https://www.ncbi.nlm.nih.gov/pubmed/34267730 http://dx.doi.org/10.3389/fendo.2021.719647 |
| work_keys_str_mv | AT estevessandroc editorialposeidonsstratificationoflowprognosispatientsinartthewhythewhatandthehow AT andersenclausyding editorialposeidonsstratificationoflowprognosispatientsinartthewhythewhatandthehow AT fischerrobert editorialposeidonsstratificationoflowprognosispatientsinartthewhythewhatandthehow AT humaidanpeter editorialposeidonsstratificationoflowprognosispatientsinartthewhythewhatandthehow AT alviggicarlo editorialposeidonsstratificationoflowprognosispatientsinartthewhythewhatandthehow |